reports
California Resources Corp: 1 director
A director at California Resources Corp sold/sold after exercising options 8,564 shares at 63.707USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's di...
- Jonathan Moreland
TPC TUTOR PERINI CORPORATION
TCBI TEXAS CAPITAL BANCSHARES INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
HTGC HERCULES CAPITAL INC.
GPK GRAPHIC PACKAGING HOLDING COMPANY
NWPP NEW PEOPLES BANKSHARES INC.
SSP THE E.W. SCRIPPS COMPANY
KKR KKR & CO. INC.
EOSE EOS ENERGY ENTERPRISES INC (A)
SLRC SOLAR CAPITAL LTD.
PFX PHENIXFIN CORP
NPWR NET POWER INC
NCDL NUVEEN CHURCHILL DIRECT LENDING CORP
MSDL MORGAN STANLEY DIRECT LENDING
EDSA EDESA BIOTECH INC
HYMC HYCROFT MINING HOLDING CORPORATION
America’s Car-Mart, Inc. Schedules Third Quarter Fiscal Year 2026 Resu...
America’s Car-Mart, Inc. Schedules Third Quarter Fiscal Year 2026 Results and Conference Call ROGERS, Ark., March 05, 2026 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) today announced it will release fiscal 2026 third quarter financial results on Thursday, March 12, 2026, before the market opens. A webcast and conference call will be held that same day at 9:00 a.m. ET to review the Company’s results. Participants may access the conference call via webcast using this link: . To participate via telephone, please register in advance using this . Upon registration, all telepho...
Duluth Holdings Inc. to Report Fourth Quarter 2025 Financial Results o...
Duluth Holdings Inc. to Report Fourth Quarter 2025 Financial Results on March 19, 2026 MOUNT HOREB, Wis., March 05, 2026 (GLOBE NEWSWIRE) -- Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s casual wear, workwear, and accessories, today announced that it will report fourth quarter 2025 financial results before market on Thursday, March 19, 2026. A conference call and audio webcast with analysts and investors will be held on Thursday, March 19, 2026, at 9:30 am Eastern Time to discuss the results and answer questio...
James River Recruits Industry Veteran Kelly Hadiaris to Lead Excess Ca...
James River Recruits Industry Veteran Kelly Hadiaris to Lead Excess Casualty CHAPEL HILL, N.C., March 04, 2026 (GLOBE NEWSWIRE) -- James River Group Holdings, Inc. ("James River" or the "Company") (NASDAQ: JRVR) today announced that Kelly Hadiaris has re-joined the Company as Senior Vice President, Underwriting – Excess Casualty, to lead the Excess Casualty division within its Excess and Surplus (“E&S”) segment. Ms. Hadiaris will report to Todd Sutherland, President of the E&S segment. Ms. Hadiaris brings more than two decades of experience in the E&S market, with deep expertise across t...
FTAI Aviation Ltd: 1 director
A director at FTAI Aviation Ltd sold 10,000 shares at 303.350USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
James River Announces Fourth Quarter 2025 Results
James River Announces Fourth Quarter 2025 Results CHAPEL HILL, N.C., March 02, 2026 (GLOBE NEWSWIRE) -- James River Group Holdings, Inc. ("James River" or the "Company") (NASDAQ: JRVR) today reported the following results for the fourth quarter 2025 as compared to the same period in 2024: Three Months EndedDecember 31, Three Months EndedDecember 31,($ in thousands, except for share data) 2025 per diluted share 2024 per diluted shareNet income (loss) from continuing operations available to common shareholders$30,150 $0.53 $(92,669) $(2.25)Net loss from discontinued operations1 (46) $—...
- David Barden
SBA Communications 4Q25 Results & Model Update
We are updating our model for SBAC (Neutral, PT $212) following its 4Q25 results that were generally behind on most metrics. As we mentioned in our initial take, the company’s 2026 guidance doesn’t show much to get excited about, however, we are interested to see the progression of its dispute with SATS. The company stated that it filed its lawsuit against SATS on 2/25/26 and removed the revenue from its guide in line with the balance of the industry. Separating itself from others in the industr...
- David Barden
SBA Communications 4Q25 Quick Take: SATS Lawsuit filed, not so much ex...
SBAC (Neutral, PT $212) reported 4Q25 results that were below our estimates and consensus. The company stated that it filed its lawsuit against SATS on 2/25/26 and removed the revenue from its guide in line with the industry. 2026 guidance came in light vs. the street, which we think is in part due to messiness around SATS. The company mentioned that it won’t likely rise to its long-term growth targets until 2028 as it continues to work through churn events in 2026 and 2027. This note is our ins...
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial ...
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results BOSTON, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter and fiscal year ended December 31, 2025. Recent Highlights: Fourth quarter 2025 revenue from Continuing Operations of $23.8 million; Full Year 2025 revenue of $85.3 millionFully operationalized over $40 million in previously announced annualized cost savings supporting path to positive adjusted EBITDA and adjusted cash flow exiting 2026Ap...
- Jonathan Moreland
VRNS VARONIS SYSTEMS INC.
UEPS NET 1 U.E.P.S. TECHNOLOGIES INC.
TWI TITAN INTERNATIONAL INC.
SLP SIMULATIONS PLUS
SCSC SCANSOURCE INC.
PSEC PROSPECT CAPITAL CORPORATION
PAYX PAYCHEX INC.
NG. NOVAGOLD RESOURCES INC.
MOH MOLINA HEALTHCARE INC.
MMS MAXIMUS INC.
LMAT LEMAITRE VASCULAR INC.
KVHI KVH INDUSTRIES INC.
GKOS GLAUKOS CORP
CINF CINCINNATI FINANCIAL CORPORATION
BMI BADGER METER INC.
ARE ALEXANDRIA REAL ESTATE EQUITIES INC.
ARCC ARES CAPITAL CORPORATION
ASA ASA
PRU PRUDENTIAL PLC
TSI TCW STRATEGIC INCOME FUND INC.
PLBC PLUMAS BANCORP
GRF EAGLE CAPITAL GROWTH FUND INC
LW LAMB WESTON HOLDINGS INC.
HWKN HAWKINS INC.
WDFC WD-40 COMPANY
PW POWER REIT
ABT ABBOTT LABORATORIES
KKR KKR & CO. INC.
AXR AMREP
SONO SONOS
TENB TENABLE HOLDINGS
AVTR AVANTOR
CMTV INC.
AON COMMUNITY BANCORP INC. VT
BSTZ AON PLC CLASS A
AFRM BLACKROCK SCIENCE AND TECHNOLOGY TRUST II
INTA AFFIRM HOLDINGS
TMC INTAPP INC
CHRW TMC THE METALS CO INC
TBBK C.H. ROBINSON WORLDWIDE
FRST INC.
QDEL THE BANCORP
CHUC INC.
PMN PRIMIS FINANCIAL CORP
HYMC QUIDEL CORP
CING CHARLIES HLDGS INC
SPGI PROMIS NEUROSCIENCES INC.
HYCROFT MINING HOLDING CORPORATION
CINGULATE INC
MCGRAW HILL FINANCIAL INC
- Jonathan Moreland
Insider Sales Into Price Weakness InsiderInsights.com Daily Ratings Re...
InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
UEPS NET 1 U.E.P.S. TECHNOLOGIES INC.
NG. NOVAGOLD RESOURCES INC.
GKOS GLAUKOS CORP
BMI BADGER METER INC.
ARCC ARES CAPITAL CORPORATION
PW POWER REIT
INTA INTAPP INC
TMC TMC THE METALS CO INC
TBBK THE BANCORP
KVUE INC.
SI KENVUE INC
CING SHOULDER INNOVATIONS INC
CINGULATE INC
Snap Inc: 1 director
A director at Snap Inc sold/gave away 2,601,453 shares at 0.000USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financ...
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 BOSTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026, after U.S. market close. About Standard BioTools Inc. Standard BioTools Inc. (Nasdaq: LAB), has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop better medicines faster. As a leading solutions provider, the comp...
James River to Hold Its Fourth Quarter Earnings Conference Call on Tue...
James River to Hold Its Fourth Quarter Earnings Conference Call on Tuesday, March 3, 2026 CHAPEL HILL, N.C., Feb. 04, 2026 (GLOBE NEWSWIRE) -- James River Group Holdings, Inc. ("James River" or the "Company") (NASDAQ: JRVR) will release fourth quarter earnings after the market closes on Monday, March 2, 2026. It will also host an earnings conference call on Tuesday, March 3, 2026 beginning at 8:30 a.m. (Eastern Time). The conference call may be accessed by dialing (800) 715-9871, conference ID 6910670, or via the investor website at . A replay will also be available in the same location....
Lesaka’s Q2 FY2026 Results: Lesaka achieves mid-point of its profitabi...
Lesaka’s Q2 FY2026 Results: Lesaka achieves mid-point of its profitability guidance and reaffirms its FY2026 full year guidance JOHANNESBURG, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the second quarter of fiscal 2026 (“Q2 2026”). Q2 2026 performance1:All growth rates are year-on-year between Q2 FY2026 and Q2 FY2025. Group LevelUSD(In thousands, except per share data) ZAR(In thousands, except per share data) Q2 FY26 Q2 FY25 Q2 FY26 Q2 FY25 YoY%Revenue178,734 176,216 3,058,191 3,155,758 (3%)Net Revenue(2)93,403 77,0...
Standard BioTools Completes Sale of SomaLogic to Illumina
Standard BioTools Completes Sale of SomaLogic to Illumina Received $350 Million in upfront cash at closing; Up to $425 Million in total proceeds inclusive of near-term earnout payments Approximately $550 Million in cash & cash equivalents on balance sheet at close, excluding potential future earnouts, to fuel inorganic growth strategy Continuing Operations on track to achieve positive adjusted EBITDA in 2026 BOSTON, Mass., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced it has completed the previously announ...
- Jonathan Moreland
SCL STEPAN COMPANY
RLI RLI CORP.
LTC LTC PROPERTIES INC.
LPTH LIGHTPATH TECHNOLOGIES INC. CL A
LMNR LIMONEIRA CO.
IPAR INTER PARFUMS INC.
GME GAMESTOP CORP. CLASS A
DAKT DAKTRONICS INC.
CMC COMMERCIAL METALS COMPANY
CGNX COGNEX CORPORATION
CASY CASEY'S GENERAL STORES INC.
CALX CALIX NETWORKS
WHF WHITEFIELD
ADC AGREE REALTY CORPORATION
PAR PAR TECHNOLOGY CORP.
EPD ENTERPRISE PRODUCTS PARTNERS L.P.
FSFG FIRST SAVINGS FINANCIAL GROUP INC.
PLBC PLUMAS BANCORP
GLO CLOUGH GLOBAL OPPORTUNITIES FUND
CLPR CLIPPER REALTY
BOMN BOSTON OMAHA
UA UNDER ARMOUR
NKE INC.
ESQ NIKE INC. CLASS B
FGBI ESQUIRE FINANCIAL HOLDINGS
GRX FIRST GUARANTY BANCSHARES
CABA THE GABELLI HEALTHCARE & WELLNESSRX TRUST
JYNT CABALETTA BIO
ALLY THE JOINT
ALT GMAC LLC
APG ALTIMMUNE INC
ZNTL API GROUP CORP
AVO ZENTALIS PHARMACEUTICALS
IVFH MISSION PRODUCE
TMC INNOVATIVE FOOD HLDG
IMRX TMC THE METALS CO INC
LUCY IMMUNEERING CORP
PMCB INNOVATIVE EYEWEAR INC
GLSI PHARMACYTE BIOTECH INC
VANI GREENWICH LIFESCIENCES INC
ACRV VIVANI MEDICAL INC
SUNS ACRIVON THERAPEUTICS INC
GF SUNRISE REALTY TRUST
MSTR THE NEW GERMANY FUND
MPTI INC.
MIGI MICROSTRATEGY INCORPORATED
SQNS M-TRON INDUSTRIES
INC.
MAWSON INFRASTRUCTURE GROUP INC
SEQUANS COMMUNICATIONS
Leidos Holdings Inc: 1 director
A director at Leidos Holdings Inc sold 3,000 shares at 192.212USD and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.